{
  "cik": 1706431,
  "cik_padded": "0001706431",
  "entityName": "Vir Biotechnology, Inc.",
  "fiscal_years": [
    {
      "accn": "0001628280-26-010749",
      "filed": "2026-02-23",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 4832000.0,
        "cash": 232185000.0,
        "eps_diluted": -3.16,
        "free_cash_flow": -396613000.0,
        "net_income": -437987000.0,
        "operating_cash_flow": -391781000.0,
        "operating_income": -479328000.0,
        "revenue": 68556000.0,
        "stockholders_equity": 765276000.0,
        "total_assets": 1002823000.0,
        "total_liabilities": 237547000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.31040696428478093,
        "revenue_growth_yoy": -0.07612694562361026,
        "roa_avg2y": -0.3647405352018374,
        "roa_period_end": -0.4367540433356634,
        "roe_avg2y": -0.4572698405406802,
        "roe_period_end": -0.5723255400665903
      }
    },
    {
      "accn": "0001628280-26-010749",
      "filed": "2026-02-23",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7301000.0,
        "cash": 222947000.0,
        "eps_diluted": -3.83,
        "free_cash_flow": -453653000.0,
        "net_income": -521960000.0,
        "operating_cash_flow": -446352000.0,
        "operating_income": -587165000.0,
        "revenue": 74205000.0,
        "stockholders_equity": 1150385000.0,
        "total_assets": 1398813000.0,
        "total_liabilities": 248428000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.21595205083515517,
        "revenue_growth_yoy": -0.13895335344627524,
        "roa_avg2y": -0.3146353100314569,
        "roa_period_end": -0.37314494503554085,
        "roe_avg2y": -0.38090637122024534,
        "roe_period_end": -0.4537263611747371
      }
    },
    {
      "accn": "0001628280-26-010749",
      "filed": "2026-02-23",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 21573000.0,
        "cash": 241576000.0,
        "eps_diluted": -4.59,
        "free_cash_flow": -800358000.0,
        "net_income": -615061000.0,
        "operating_cash_flow": -778785000.0,
        "operating_income": -684305000.0,
        "revenue": 86180000.0,
        "stockholders_equity": 1590236000.0,
        "total_assets": 1919060000.0,
        "total_liabilities": 328824000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.20677685576228938,
        "revenue_growth_yoy": -0.9466640920858251,
        "roa_avg2y": -0.2605556953520627,
        "roa_period_end": -0.3205011828707805,
        "roe_avg2y": -0.33534767334051396,
        "roe_period_end": -0.386773409732895
      }
    },
    {
      "accn": "0001628280-26-010749",
      "filed": "2026-02-23",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 68006000.0,
        "cash": 848631000.0,
        "eps_diluted": 3.83,
        "free_cash_flow": 1595247000.0,
        "net_income": 515837000.0,
        "operating_cash_flow": 1663253000.0,
        "operating_income": 833068000.0,
        "revenue": 1615797000.0,
        "stockholders_equity": 2077963000.0,
        "total_assets": 2802088000.0,
        "total_liabilities": 724125000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.34847829340560926,
        "net_margin": 0.31924616768071734,
        "operating_margin": 0.5155771424256884,
        "revenue_growth_yoy": 0.4750546596495392,
        "roa_avg2y": 0.21690428554969393,
        "roa_period_end": 0.18409022129212216,
        "roe_avg2y": 0.29393996031696284,
        "roe_period_end": 0.24824166744066184
      }
    },
    {
      "accn": "0001628280-25-008245",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 21817000.0,
        "cash": 347815000.0,
        "eps_diluted": 3.96,
        "free_cash_flow": -69406000.0,
        "net_income": 528584000.0,
        "operating_cash_flow": -47589000.0,
        "operating_income": 420751000.0,
        "revenue": 1095415000.0,
        "stockholders_equity": 1431849000.0,
        "total_assets": 1954268000.0,
        "total_liabilities": 522419000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.36485621039648736,
        "net_margin": 0.4825422328523893,
        "operating_margin": 0.38410191571230995,
        "revenue_growth_yoy": 13.343900586633145,
        "roa_avg2y": 0.36796287124146676,
        "roa_period_end": 0.2704767206954215,
        "roe_avg2y": 0.4920033080451864,
        "roe_period_end": 0.36916183200882213
      }
    },
    {
      "accn": "0001628280-24-006852",
      "filed": "2024-02-26",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6549000.0,
        "cash": 436575000.0,
        "eps_diluted": -2.51,
        "free_cash_flow": -197490000.0,
        "net_income": -298665000.0,
        "operating_cash_flow": -190941000.0,
        "operating_income": -296980000.0,
        "revenue": 76368000.0,
        "stockholders_equity": 716852000.0,
        "total_assets": 918761000.0,
        "total_liabilities": 201909000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.28166064961805226,
        "revenue_growth_yoy": 8.438635520949203,
        "roa_avg2y": -0.4174703948471938,
        "roa_period_end": -0.32507365898204216,
        "roe_period_end": -0.4166341169446413
      }
    },
    {
      "accn": "0000950170-22-002295",
      "filed": "2022-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8940000.0,
        "cash": 109335000.0,
        "eps_diluted": -5.76,
        "free_cash_flow": -138572000.0,
        "net_income": -174683000.0,
        "operating_cash_flow": -129632000.0,
        "operating_income": -177979000.0,
        "revenue": 8091000.0,
        "total_assets": 512071000.0,
        "total_liabilities": 88129000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.24156355455568054,
        "roa_avg2y": -0.49649336973312663,
        "roa_period_end": -0.34113042917876624
      }
    },
    {
      "accn": "0001564590-21-008915",
      "filed": "2021-02-25",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 8192000.0,
        "cash": 47598000.0,
        "free_cash_flow": -102288000.0,
        "net_income": -115884000.0,
        "operating_cash_flow": -94096000.0,
        "operating_income": -118692000.0,
        "revenue": 10668000.0,
        "total_assets": 191596000.0,
        "total_liabilities": 61636000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 2.9394387001477105,
        "roa_period_end": -0.6048351740119835
      }
    },
    {
      "accn": "0001564590-20-013194",
      "filed": "2020-03-26",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD"
      },
      "fundamentals": {
        "capex": 2742000.0,
        "cash": 187918000.0,
        "free_cash_flow": -69123000.0,
        "net_income": -69852000.0,
        "operating_cash_flow": -66381000.0,
        "operating_income": -81497000.0,
        "revenue": 2708000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001628280-26-010749",
    "filed": "2026-02-23",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001706431.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001706431.json"
  },
  "ticker": "VIR"
}
